Diprivan and Roxicet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Roxicet (acetaminophen; oxycodone hydrochloride). Common drug interactions include mastication disorder among females and abscess neck among males.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Roxicet. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Roxicet?

Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.

On Jul, 11, 2026

24 people who take Diprivan and Roxicet together, and have interactions are studied.

What are the common drug interactions of Diprivan and Roxicet, by gender? *:

female:

Mastication disorder (disease of chewing food)
Osteonecrosis of jaw (death of bone of jaw)
Spinal compression fracture (fracture due to spinal compression on bone)
Back disorder
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Abscess jaw (tooth abscess or root abscess)
Activities of daily living impaired
Anaemia (lack of blood)
Anxiety
Asthenia (weakness)

male:

Abscess neck (neck abscesses)
Addison's disease (addison's disease, a hormonal disorder disease)
Arthralgia (joint pain)
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bone disorder
Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
Breast haematoma (blood-filled swelling in the breast)
Cardiac arrest
Cardiac disorder

What are the common drug interactions of Diprivan and Roxicet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Disease progression
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Non-small cell lung cancer (type of epithelial lung cancer)
Death
Pulse absent
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

40-49:

n/a

50-59:

Coagulopathy (blood's ability to clot is impaired)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Deafness
Decreased appetite
Dilatation ventricular
Dysgeusia (disorder of the sense of taste)
Dysphagia (a condition in which swallowing is difficult or painful)
Ejection fraction decreased (systolic heart failure)
Enterococcus test positive
Extremity necrosis (death of body tissue of arms and legs)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bone disorder
Osteopenia (a condition where bone mineral density is lower than normal)
Pain in jaw
Abscess jaw (tooth abscess or root abscess)
Activities of daily living impaired
Anaemia (lack of blood)
Anxiety
Asthenia (weakness)
Asthma

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 12 people, 50.00%
Multiple Myeloma (cancer of the plasma cells): 11 people, 45.83%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 11 people, 45.83%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Roxicet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously